Artificial Intelligence, Machine Learning, and Deep Learning

Share:

EmailFacebookLinkedInXWhatsAppShare
Supports the design and development of artificial intelligence, machine learning, and deep learning to enhance analysis of complex medical images and data.

Emphasis

The emphasis is on development of transformative machine intelligence-based systems, emerging tools, and modern technologies for diagnosing and recommending treatments for a range of diseases and health conditions.  Unsupervised and semi-supervised techniques and methodologies are of particular interest.

Program priorities and areas of interest:

  • clinical decision support systems
  • computer-aided diagnosis
  • computer-aided screening
  • analyzing complex patterns and images
  • screening for diseases
  • natural-language processing and understanding
  • medical decision-making
  • predictive modeling
  • computer vision
  • robotic and image guided surgery
  • personalized imaging and treatment
  • drug discovery
  • radiomics
  • machine/deep learning-based segmentation, registration, etc.

Additional support

This program also supports:

  • early-stage development of software, tools, and reusable convolutional neural networks
  • data reduction, denoising, improving performance (health-promoting apps), and deep-learning based direct image reconstruction
  • approaches that facilitate interoperability among annotations used in image training databases

    Related News

    May 16, 2024

    Columbia University biomedical engineers have created BeatProfiler, a new comprehensive tool that uses AI to analyze heart cell function. It's the first system to integrate the analysis of different heart function indicators, such as contractility, calcium handling, and force output into one tool, speeding up the process significantly and reducing the chance for errors.  Source: Columbia University Engineering.

    May 14, 2024

    A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.

    May 10, 2024

    Researchers from Mass General Brigham and their collaborators present Tripath: new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions. In collaboration with the University of Washington, the research team imaged curated prostate cancer specimens, using two 3D high-resolution imaging techniques. Tripath performed better than pathologists and outperformed deep learning models that rely on 2D morphology and thin tissue slices. Source: Mass General Brigham

    May 9, 2024
    A photograph of a mechanoacoustic mouse implant

    Measuring heart rate or body temperature may sound easy, but retrieving the data from small animals with bulky traditional tech is difficult, especially during behavioral tests, which are critical for understanding brain disorders. Thanks to a recent study, the animal data is now in reach.

    May 7, 2024

    Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. A preclinical study in Pharmaceutics shows that combining focused ultrasound with microbubbles opened the blood brain barrier to deliver immunotherapy into the brain of a large animal model.